Amyloid-beta and tau protein beyond Alzheimer’s disease

Amyloid-beta and tau protein beyond Alzheimer’s disease

The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer’s disease pathogenesis and are considered the main pathological hallmarks of this devastating disease. Physiologically, these two proteins are produced and expressed within the normal...

Full description

Bibliographic Details
Main Authors:	Morteza Abyadeh, Vivek Gupta, Joao A Paulo, Arezoo Gohari Mahmoudabad, Sina Shadfar, Shahab Mirshahvaladi, Veer Gupta, Christine T O. Nguyen, David I Finkelstein, Yuyi You, Paul A Haynes, Ghasem H Salekdeh, Stuart L Graham, Mehdi Mirzaei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Neural Regeneration Research
Subjects:	amyloid-beta; cancer; cardiovascular diseases; diabetes; neurodegeneration; tau; traumatic brain injury
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1262;epage=1276;aulast=Abyadeh

Similar Items

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
by: Jurre den Haan, et al.
Published: (2018-12-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model
by: Zhen-Dong Sun, et al.
Published: (2022-01-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)

Prion-associated cerebral amyloid angiopathy is not exacerbated by human phosphorylated tau aggregates in scrapie-infected mice expressing anchorless prion protein
by: Brent Race, et al.
Published: (2020-10-01)

Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus)
by: Yuta Takaichi, et al.
Published: (2021-01-01)

Neurotrophin receptor p75 mediates amyloid β-induced tau pathology
by: Lin-Lin Shen, et al.
Published: (2019-12-01)

Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01)

Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools
by: Vanlalrinchhani Varte, et al.
Published: (2023-04-01)

Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
by: Seyed Hani Hojjati, et al.
Published: (2023-01-01)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
by: Cécile Tissot, et al.
Published: (2021-01-01)

The Roles of Lipid and Glucose Metabolism in Modulation of β-Amyloid, Tau, and Neurodegeneration in the Pathogenesis of Alzheimer disease
by: Naoyuki eSato, et al.
Published: (2015-10-01)

Dual regulatory effects of neferine on amyloid-β and tau aggregation studied by in silico, in vitro, and lab-on-a-chip technology
by: Yunkwon Nam, et al.
Published: (2024-03-01)

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
by: Noemi Esteras, et al.
Published: (2020-09-01)

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
by: Shweta S. Puntambekar, et al.
Published: (2022-06-01)

Biomarkers in the diagnosis of neurodegenerative diseases
by: Syed S. Haque
Published: (2022-12-01)

Structure-based inhibitors of amyloid beta core suggest a common interface with tau
by: Sarah L Griner, et al.
Published: (2019-10-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
by: Lauren E. McCollum, et al.
Published: (2021-01-01)

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
by: Woo Shik Shin, et al.
Published: (2019-10-01)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
by: Yam Nath Paudel, et al.
Published: (2020-06-01)

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA
by: Matthias Brendel, et al.
Published: (2020-06-01)

Language dysfunction correlates with cognitive impairments in older adults without dementia mediated by amyloid pathology
by: Chunchen Xiang, et al.
Published: (2023-05-01)

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
by: Yue Cai, et al.
Published: (2023-02-01)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
by: Artur Sulik, et al.
Published: (2022-03-01)

Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
by: Valentina Latina, et al.
Published: (2021-03-01)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
by: Guilherme Povala, et al.
Published: (2021-12-01)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
by: Gro Gujord Tangen, et al.
Published: (2023-02-01)

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease
by: Cherie Strikwerda-Brown, et al.
Published: (2023-01-01)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
by: Xue‐Ning Shen, et al.
Published: (2021-01-01)

GSK3 and Alzheimer's disease: facts & fiction …
by: Fred eVanleuven
Published: (2011-08-01)

Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
by: Georgia R. Frost, et al.
Published: (2019-12-01)

Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01)

Deleterious and protective effects of epothilone-D alone and in the context of amyloid β- and tau-induced alterations
by: Ángel Abdiel Robles-Gómez, et al.
Published: (2023-10-01)

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
by: Evgenia Salta, et al.
Published: (2016-09-01)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
by: Sarah Westwood, et al.
Published: (2018-12-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01)

Hsp40s play complementary roles in the prevention of tau amyloid formation
by: Rose Irwin, et al.
Published: (2021-08-01)

Coumarin derivatives against amyloid-beta 40 – 42 peptide and tau protein
by: Kowalczyk Joanna, et al.
Published: (2022-08-01)